In comparison with the CM11 peptide, modified peptide exhibited similar antimicrobial activity against clinical isolates of antibiotic-resistant B. melitensis with a reduction in hemolytic and cytotoxicity activates. Also, the synergistic effect between modified peptide and streptomycin and rifampin was ...